G Pastorino

Author PubWeight™ 14.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Neutrophil dysfunction and increased susceptibility to infection. Eur J Clin Invest 1995 1.45
2 Phase-II study of Navelbine in advanced breast cancer. Semin Oncol 1989 1.09
3 Right-sided bacterial endocarditis due to Flavobacterium odoratum in a patient on chronic hemodialysis. Am J Nephrol 1995 1.03
4 Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. J Clin Oncol 1988 1.01
5 Evaluation of the effects induced by four opiate drugs, with different affinities to opioid receptor subtypes, on anterior pituitary LH, TSH, PRL and GH secretion and on cortisol secretion in normal men. Biomed Pharmacother 1986 0.84
6 Cytoprotection against neutrophil-delivered oxidant attack by antibiotics. Biochem Pharmacol 1991 0.83
7 The drug 5-aminosalicylic acid rescues alpha 1-proteinase inhibitor from the neutrophil oxidative inactivation. A possible contribution to its therapeutic action in ulcerative colitis. Digestion 1992 0.81
8 Enoxaparin in the prevention of deep venous thrombosis after major surgery: multicentric study. The Italian Study Group. Int Surg 1994 0.81
9 Phase II study of tamoxifen and high-dose retinyl acetate in patients with advanced breast cancer. J Cancer Res Clin Oncol 1990 0.81
10 Rio de La Plata study: a multicenter, cross-sectional study on cardiovascular risk factors and heart failure prevalence in peritoneal dialysis patients in Argentina and Uruguay. Kidney Int Suppl 2008 0.80
11 Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer. Cancer Treat Rep 1987 0.79
12 Paclitaxel plus ifosfamide in advanced ovarian cancer: a multicenter phase II study. Oncology 1997 0.78
13 A hospital based universal neonatal hearing screening programme using click-evoked otoacoustic emissions. Scand Audiol Suppl 2001 0.78
14 Nimesulide as a downregulator of the activity of the neutrophil myeloperoxidase pathway. Focus on the histoprotective potential of the drug during inflammatory processes. Drugs 1993 0.78
15 Inhibition of the neutrophil oxidative response induced by the oral administration of nimesulide in normal volunteers. J Clin Lab Immunol 1992 0.78
16 Oral tramadol and buprenorphine in tumour pain. An Italian multicentre trial. Int J Clin Pharmacol Res 1996 0.77
17 Early diagnosis of optic glioma in children with neurofibromatosis type 1. Childs Nerv Syst 1994 0.77
18 Genotoxicity testing of chloramphenicol in rodent and human cells. Mutat Res 1991 0.76
19 Pattern-reversal visual evoked potentials and EEG correlations in common migraine patients. Headache 1988 0.76
20 [Effects of injectable flunitrazepam on hepatic and cardiac output in man]. Ann Fr Anesth Reanim 1985 0.75
21 [Diagnostic and therapeutic problems in lesions caused by caustics in the upper digestive tract]. Chir Ital 1981 0.75
22 [Clinical improvement induced by chemotherapy and social rehabilitation in a preterminal case of brain stem neoplasm: the objective and instrumental aspects]. Pediatr Med Chir 1993 0.75
23 [Primary tumors of the small intestine]. Arch Sci Med (Torino) 1982 0.75
24 [Comparison of 2 protocols of polychemotherapy in the treatment of invasive carcinoma of the breast]. Minerva Med 1981 0.75
25 [Thoracic surgery with a video endoscopic technic. The authors' own experience]. Minerva Chir 1994 0.75
26 [Primary neoplasms of the hilus hepatis. Radical treatment]. Minerva Chir 1985 0.75
27 [Pancreatic cysts]. Minerva Chir 1986 0.75
28 [2 cases of Brunner's glands adenoma of the duodenum]. Minerva Gastroenterol 1976 0.75
29 [Use of minitracheotomy in high-risk pulmonary resection surgery. Results of a comparative study]. Minerva Chir 1994 0.75
30 [Primary intrahepatic calculosis]. Minerva Dietol Gastroenterol 1987 0.75
31 [The value of therapeutic needle aspiration in Reclus' disease]. Minerva Med 1982 0.75
32 [Chemico-experimental data on the principal bile constituents in patients with obstructive jaundice]. Clin Ter 1989 0.75
33 [The surgical therapy of pulmonary aspergilloma. Our experience]. Minerva Chir 1991 0.75
34 [Biliary ileus. Observation of 10 cases]. Arch Sci Med (Torino) 1982 0.75
35 [The possible evaluation of immunity with the DNCB skin test in relation to blast transformation of lymphocytes]. Minerva Med 1982 0.75
36 [Surgery in the treatment of pulmonary carcinoma with mediastinal lymph node metastasis (N2)]. Minerva Chir 1991 0.75
37 [Non-surgical treatment of postoperative fistulas of the proximal portion of the digestive tract using parenteral hyperalimentation]. Arch Sci Med (Torino) 1975 0.75
38 A new benzodiazepine: electroencephalographic studies of its anticonvulsant activity in non-anesthetized, non-curarized rabbits. Arzneimittelforschung 1969 0.75
39 [Tumor markers in metastatic breast carcinoma: correlations with clinical response]. J Nucl Med Allied Sci 1991 0.75
40 Combination of epirubicin and lonidamine for treatment of advanced breast cancer. Tumori 1995 0.75
41 Megestrol acetate: phase II study of a single daily administration in advanced breast cancer. Breast Cancer Res Treat 1990 0.75
42 [Papillosphincteroplasty and wirsungsphincteroplasty. 10 years of experience]. Minerva Chir 1981 0.75
43 A randomized trial of chemotherapy with or without estrogenic recruitment in locally advanced breast cancer. North-West Oncology Group (GONO) Study, Italy. Tumori 1998 0.75
44 [Acute post-traumatic and post-operative non-calculous cholecystitis. 6 cases]. Minerva Dietol Gastroenterol 1982 0.75
45 Cisplatin and 5-fluorouracil in refractory breast cancer patients: a phase II study. Breast Cancer Res Treat 1988 0.75
46 [Tracheobronchial reconstructive surgery: protection of the tracheal anastomosis. Our experience]. Minerva Chir 1994 0.75
47 [Use of calcitonin in neoplastic osteolysis]. Minerva Med 1983 0.75
48 [The use of a detoxicant drug in the treatment of alcoholic toxicosis]. Minerva Med 1970 0.75
49 [The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms]. Minerva Med 1979 0.75
50 [Surgical resection of exocrine neoplasms of the pancreatic head: indications and requirements]. Chir Ital 1994 0.75
51 [Transcutaneous treatment of residual/recurrent calculosis of the bile ducts]. Minerva Chir 1985 0.75
52 Interleukin-8 down-regulates the oxidative burst induced by tumor necrosis factor alpha in neutrophils adherent to fibronectin. Eur Cytokine Netw 1994 0.75
53 [Our experience in surgical treatment of tumors of the upper biliary junction]. Minerva Chir 1983 0.75
54 [The epicutaneous DNCB test and CEA determination in neoplasms of the breast, digestive tract, lung and urogenital system]. Minerva Med 1979 0.75
55 Ibuprofen inhibits adhesion-dependent neutrophil response by a glycoprotein-unrelated mechanism. Drugs Exp Clin Res 1992 0.75
56 Percutaneous transhepatic cholangioscopy. Int Surg 1984 0.75
57 Technique and endoscopic monitoring of the healing process in bilioenteric anastomoses. Int Surg 1988 0.75
58 [Comparison of two nonspecific immune stimuli in antiblastic chemotherapy]. Arch Sci Med (Torino) 1981 0.75
59 [Automatic sutures in bronchopulmonary surgery]. G Chir 1990 0.75
60 Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial. Cancer Chemother Pharmacol 2011 0.75
61 Synchronous occurrence of pulmonary adenocarcinoma and pleural diffuse malignant mesothelioma. Pathologica 2013 0.75
62 [Percutaneous transhepatic cholangiography and percutaneous transhepatic biliary drainage in the diagnosis and therapy of cholestatic icterus]. Minerva Chir 1983 0.75
63 Stimulation of human breast cancer in vivo. Experimental findings and clinical results. Ann N Y Acad Sci 1993 0.75
64 [Immunochemotherapeutic treatment of gastrointestinal neoplasms]. Minerva Med 1981 0.75